Count | |
1 | |
2 | |
Dideoxynucleosides/adverse effects/pharmacokinetics/*therapeutic use | 1 |
1 | |
Dideoxynucleosides/adverse effects/*pharmacokinetics/*therapeutic use | 1 |
3 | |
8 | |
4 | |
1 | |
8 | |
1 | |
2 | |
1 | |
1 | |
14 | |
1 | |
2 | |
2 | |
3 | |
3 | |
1 | |
1 | |
4 | |
2 | |
3 | |
1 | |
1 | |
1 | |
2 | |
Dideoxynucleosides/administration & dosage/*therapeutic use/toxicity | 1 |
2 | |
Dideoxynucleosides/*chemical synthesis/chemistry/pharmacology | 1 |
2 | |
36 | |
1 | |
43 | |
1 | |
2 | |
2 | |
1 | |
1 | |
2 | |
1 | |
5 | |
1 | |
1 | |
1 | |
3 | |
2 | |
2 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
2 | |
1 | |
1 | |
2 | |
2 | |
2 | |
1 | |
3 | |
3 | |
2 | |
1 | |
1 | |
1 | |
1 | |
3 | |
1 | |
2 | |
1 | |
2 | |
2 | |
2 | |
2 | |
1 | |
2 | |
2 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
3 | |
3 | |
2 | |
1 | |
2 | |
3 | |
1 | |
1 | |
1 | |
1 | |
2 | |
2 | |
1 | |